搜尋結果
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
CNBC· 54 分鐘前The Food and Drug Administration on Friday expanded the approval of GSK's respiratory ...
Jim Cramer's week ahead: Fed meeting and CPI report
CNBC· 47 分鐘前CNBC's Jim Cramer on Friday guided investors through next week's most market-moving ...